Invention Grant
- Patent Title: 2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
-
Application No.: US15125373Application Date: 2015-03-09
-
Publication No.: US09775839B2Publication Date: 2017-10-03
- Inventor: Michael D. Altman , Brandon Cash , John Michael Ellis , Matthew L. Maddess , Alan B. Northrup , Ryan D. Otte , Binyuan Sun
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Eric A. Meade; Catherine D. Fitch
- International Application: PCT/US2015/019349 WO 20150309
- International Announcement: WO2015/138273 WO 20150917
- Main IPC: A61K31/497
- IPC: A61K31/497 ; C07D403/04 ; C07D403/14 ; C07D405/04 ; C07D405/14 ; C07D409/14 ; A61K45/06 ; C07D401/14 ; C07D471/04 ; C07D491/056
Abstract:
The invention provides certain pyrazine-2-carboxamide compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein A, B, and X are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).
Public/Granted literature
- US20170071935A1 2-PYRAZINE CARBOXAMIDES AS SPLEEN TYROSINE KINASE INHIBITORS Public/Granted day:2017-03-16
Information query
IPC分类:
